Aifa authorizes 8 influenza vaccines for 2024-2025 campaign

ROME (ITALPRESS) – Eight vaccines have been authorized by Aifa and the European Medicines Agency (Ema) for immunization against seasonal influenza for the 2024-205 campaign. As every year, the viral strains were updated according to World Health Organization recommendations based on the antigenic characteristics of the viral strains circulating in the last season. The vaccines authorized by Aifa through mutual recognition and decentralized procedures are: Efluelda Tetra (Sanofi Pasteur), injectable suspension: indicated for active immunization of adults aged 60 years and older.Fluarix Tetra (Glaxosmithkline Biologicals), injectable suspension: indicated for active immunization of adults and children 6 months of age and older.Influvac S (Viatris Healthcare Limited), injectable suspension: indicated for active immunization of adults and children 6 months of age and older.Influvac S Tetra (Viatris Healthcare Limited), injectable suspension: indicated for active immunization of adults and children from 6 months of age.Vaxigrip Tetra (Sanofi Pasteur Eeurope), injectable suspension: indicated for active immunization of adults, including pregnant women, and children from 6 months of age. Maternal vaccination of pregnant women extends protection to infants from birth to 6 months of age (passive protection). Vaccines authorized under a centralized procedure (coordinated by Ema) are: Fluad Tetra (Seqirus Netherlands), adjuvanted, injectable suspension: indicated for active immunization of adults (aged 50 years and older).Flucelvax Tetra (Seqirus Netherlands B.V.), injectable suspension: indicated for active immunization of adults and children from 24 months of age.Fluenz (Astrazeneca AB) nasal spray: indicated for active immunization in children and adolescents aged 24 months to 18 years. Not all vaccines licensed for use are necessarily available on the market. In fact, regions decide annually, through tenders for the supply of vaccines, among commercially available products, those that will be used during vaccination campaigns. The Ministry of Health has recommended that regional flu vaccination campaigns be conducted from the beginning of October.(ITALPRESS).-Photo: Photo Agency-